Emcure Pharmaceuticals (EMCURE) — Announcement

📢 Key Event
CARE Ratings reaffirms Emcure's credit ratings with Stable outlook and increases long-term facility to Rs 785 crore.

🔄 What Changed
Long-term facility amount increased from Rs 557.50 crore to Rs 785.00 crore.

🔮 What's Next
NA

💡 Investor Takeaway
This rating reaffirmation and facility increase signal stronger lender confidence in Emcure's growth and financial stability.

CARE Ratings reaffirmed Emcure Pharmaceuticals' credit ratings with a Stable outlook, raising its long-term facility to Rs 785 crore from Rs 557.50 crore, reflecting strong FY26 performance with 18% revenue growth to Rs 9,322 crore and a 20% PBILDT margin. The company highlighted diversified products, international expansion, and a comfortable capital structure, while noting regulatory and competition risks. This credit rating action underscores confidence in Emcure's financial resilience and growth trajectory amid sector challenges.

📄 View Original Announcement (PDF)

📊 Stock Analysis — EMCURE ✨ Ask AI About This

About Emcure Pharmaceuticals Ltd (EMCURE)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹35,011.16 Cr P/E: 34.6 ROE: 22.9% ROCE: 29.7% Div Yield: 0.20%

View full EMCURE stock details →

📡 Get AI alerts when EMCURE files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track EMCURE — Free

💡 Ask AI about this filing

"How does the new Rs 785 crore facility compare to Emcure's total debt?" "What specific risks does Emcure identify for its international operations?" "How does the 20% PBILDT margin compare to peers in the pharma sector?"

Ask AI Free →

📊 More EMCURE filings

See all EMCURE filings →

🔥 Also filed on 1 September 2026

FORTIS Fortis Healthcare Ltd Announcement JNPR Juniper Green Energy Ltd Announcement 544083 Shree Marutinandan Tubes Ltd Annual Report SUDARSCHEM Sudarshan Chemical Industries Ltd Announcement CORDSCABLE Cords Cable Industries Ltd Annual Report SUNPHARMA Sun Pharmaceutical Industries Ltd Announcement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when EMCURE files new disclosures

Track EMCURE filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track EMCURE — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd